Phase I/II clinical trials of carbon ion therapy for prostate cancer

The Prostate ◽  
2003 ◽  
Vol 58 (3) ◽  
pp. 252-258 ◽  
Author(s):  
Koichiro Akakura ◽  
Hirohiko Tsujii ◽  
Shinroku Morita ◽  
Hiroshi Tsuji ◽  
Tsuguo Yagishita ◽  
...  
2016 ◽  
Vol 118 (1) ◽  
pp. 136-140 ◽  
Author(s):  
Mai Fukahori ◽  
Naruhiro Matsufuji ◽  
Takeshi Himukai ◽  
Nobuyuki Kanematsu ◽  
Hideyuki Mizuno ◽  
...  

2006 ◽  
Vol 66 (4) ◽  
pp. 1084-1091 ◽  
Author(s):  
Hitoshi Ishikawa ◽  
Hiroshi Tsuji ◽  
Tadashi Kamada ◽  
Naoki Hirasawa ◽  
Takeshi Yanagi ◽  
...  

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 3638-3638
Author(s):  
S. Yamada ◽  
T. Kamada ◽  
S. Yasuda ◽  
H. Tsujii ◽  
T. Ochiai ◽  
...  

2008 ◽  
Vol 72 (4) ◽  
pp. 1010-1015 ◽  
Author(s):  
Masaru Wakatsuki ◽  
Hiroshi Tsuji ◽  
Hitoshi Ishikawa ◽  
Takeshi Yanagi ◽  
Tadashi Kamada ◽  
...  

2019 ◽  
Vol 15 (26) ◽  
pp. 3081-3095 ◽  
Author(s):  
Lina Wang ◽  
Xiaohu Wang ◽  
Qiuning Zhang ◽  
Juntao Ran ◽  
Yichao Geng ◽  
...  

This Systematic Review summarizes the literatures of clinical trials on the efficacy and safety of carbon ion therapy for gynecological carcinomas. The protocol is detailed in the online PROSPERO database, registration no. CRD42019121424, and a final set of eight studies were included. In the treatment of cervical carcinomas, both carbon ion therapy alone and carbon ion therapy concurrent chemotherapy have presented good efficacy. Besides, the efficacy of inoperable endometrial carcinomas and gynecological melanoma are similar to that of surgical treatment. In terms of safety, gastrointestinal and genitourinary toxicities are low and could be controlled by limiting the volume and dose of intestinal tract and bladder. Carbon ion radiotherapy could be considered a safe, effective and feasible therapy for gynecological carcinomas.


2014 ◽  
Vol 111 ◽  
pp. S217
Author(s):  
M. Fukahori ◽  
T. Himukai ◽  
N. Matsufuji ◽  
N. Kanematsu ◽  
H. Tsuji ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document